Elisa Stein | International ME/CFS Conference 2025: Efficacy of repeated immunoadsorption in ME/CFS скачать в хорошем качестве

Elisa Stein | International ME/CFS Conference 2025: Efficacy of repeated immunoadsorption in ME/CFS

Dr Elisa Stein presented results from an observational study involving 20 patients with ME/CFS or Long COVID. Seven individuals showed no change, while 14 responded to the therapy, showing improved functional status, a reduction in immunoglobulins and autoantibodies, and a reduction in Post-exertional Malaise (PEM) and pain. These indicate that immunoadsorption can improve the symptoms of ME/CFS and Long COVID. However, the effects are not permanent, as antibody-producing cells are not reduced. 🔗 More Details: https://events.mecfs-research.org/en/... 🔔 Subscribe to our channel so you won’t miss any updates or presentations from the International ME/CFS Conference 2025! Other interesting links: 👉 Report on the societal costs of ME/CFS and Long COVID in Germany: https://mecfs-research.org/costreport... 👉 Official Website of the International ME/CFS Conference 2025: https://events.mecfs-research.org/en/... 👉 ME/CFS Research Register: https://mrr.mecfs-research.org/